Many patients are looking forward to trying the new inhaled insulin, Exubera
Many patients are looking forward to trying the new inhaled insulin, Exubera, when it comes out later this summer.
It will be an alternative to short-acting mealtime insulin.
It has a fast onset like Humalog or Novolog...but a longer duration like regular insulin (Humulin R, etc).
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote